1. Home
  2. DRMA vs POM Comparison

DRMA vs POM Comparison

Compare DRMA & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

SELL

Current Price

$1.12

Market Cap

5.6M

Sector

Health Care

ML Signal

SELL

Logo POMDOCTOR LIMITED American Depositary Shares

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$1.00

Market Cap

6.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
DRMA
POM
Founded
2014
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
6.5M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DRMA
POM
Price
$1.12
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 20.6K
20.3K
Earning Date
11-13-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$650.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$0.06
52 Week High
$5.18
$6.43

Technical Indicators

Market Signals
Indicator
DRMA
POM
Relative Strength Index (RSI) 41.16 59.69
Support Level $1.09 $0.17
Resistance Level $1.40 $1.13
Average True Range (ATR) 0.06 0.14
MACD 0.00 0.02
Stochastic Oscillator 31.58 84.17

Price Performance

Historical Comparison
DRMA
POM

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.

Share on Social Networks: